Issue 5, 2024

Heparin sodium enriched gelatin/polycaprolactone based multi-layer nanofibrous scaffold for accelerated wound healing in diabetes

Abstract

Multilayered nanofibrous scaffolds (MNSs) obtained by electrospinning have gained widespread attention owing to their control over the delivery of drugs. However, polymer and drug solubility issues in common solvent systems still limit their applications. The present work employed acetic acid : water : ethyl acetate (4 : 4 : 2 v/v/v) as a common solvent system for dissolving gelatin and heparin sodium (HS). A GL 20% w/v solution showing optimum viscosity and conductivity, and high encapsulation (89.2 ± 2.13%) was selected. Additionally, TPGS-1000 incorporated in GL reduced the surface tension for better electrospinning and additional free-radical scavenging activity (∼6 fold of blank nanofibers). The central layer was surrounded by upper and lower PCL–GL layers to control the release of the hydrophilic drug (HS). The electrospun PCL : GL layer sustained the release for ∼24 hours. The developed multilayered nanofibrous scaffolds showed accelerated wound healing in a diabetic rat model. Histological analysis of the wound confirmed the accelerated re-epithelialization and reduced inflammatory response. Laser Doppler flowmetry further showed a significant improvement in the blood flow at the wound site at day 14 and day 21, revealing neovascularization. Therefore, the developed multilayered nanofibrous scaffolds provided a plausible method for fabricating regenerative scaffolds for drug delivery and diabetic wound healing.

Graphical abstract: Heparin sodium enriched gelatin/polycaprolactone based multi-layer nanofibrous scaffold for accelerated wound healing in diabetes

Article information

Article type
Paper
Submitted
30 Apr 2024
Accepted
15 Oct 2024
First published
25 Nov 2024
This article is Open Access
Creative Commons BY-NC license

RSC Pharm., 2024,1, 1021-1032

Heparin sodium enriched gelatin/polycaprolactone based multi-layer nanofibrous scaffold for accelerated wound healing in diabetes

M. R. Dhondale, M. Manjit, A. Jha, M. Kumar, K. Bharti, D. Kumar and B. Mishra, RSC Pharm., 2024, 1, 1021 DOI: 10.1039/D4PM00130C

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements